腺苷酸环化酶(AC)抑制剂,NKY80 是一种有效的,选择性和非竞争性的 V 型腺苷酸环化酶 (AC) 异构体抑制剂,对于 V 型,III 型和 II 型,IC50 分别为 8.3 µM,132 µM 和 1.7 mM。NKY80 是一种非核苷的喹唑啉酮,可调节心脏和肺组织中的 AC 催化活性。
生物活性
NKY80 is a potent, selective and non-competitive adenylyl cyclase (AC) type V isoform inhibitor with IC50s of 8.3 μM, 132 μM and 1.7 mM for type V, III and II, respectively. NKY80 is a non-nucleoside quinazolinone and regulates the AC catalytic activity in heart and lung tissues.
性状
Solid
IC50 & Target[1][2]
IC50: 8.3 μM (AC type V), 132 μM (AC type III) and 1.7 mM (AC type II)
体外研究(In Vitro)
NKY80 (20 μM) blocks the elevations in both LVP and ventricular cAMP levels produced by the maximal concentration (10 nM).
NKY80 (20 μM; 2 hours) completely blocks the increase in both cAMP content and renin release from isolated JG cells.
Medlife has not independently confirmed the accuracy of these methods. They are for reference only.